These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17172943)

  • 1. National collaborative study groups: structure, benefits gained and potential for rare genetic diseases.
    Moore TB; McCabe ER
    Genet Med; 2006 Dec; 8(12):793-6. PubMed ID: 17172943
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic conditions and the Social and Human Cciences of health: contributions to the debate.
    Barbosa RL; Barsaglini R; Kelly S
    Cien Saude Colet; 2019; 24(10):3604. PubMed ID: 31576990
    [No Abstract]   [Full Text] [Related]  

  • 3. My Digital Refuge.
    Wexler A
    JAMA; 2024 May; 331(20):1707-1708. PubMed ID: 38696211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative cancer research: progress report from the Indian Pediatric Oncology Group.
    Arora RS; Raj R; Mahajan A; Radhakrishnan N; Chinnaswamy G; Banavali S
    Lancet Child Adolesc Health; 2021 Apr; 5(4):239-240. PubMed ID: 33743204
    [No Abstract]   [Full Text] [Related]  

  • 5. Collaborative Research: An Advanced Practice Nurse's Experience in Genome Research and Treatment.
    Barnby E; Alexander S
    Clin Nurse Spec; 2017; 31(4):191-194. PubMed ID: 28594669
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare Tumors in Children: Progress Through Collaboration.
    Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
    J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies.
    Weiss AR; Nichols CR; Freyer DR
    Semin Oncol; 2015 Oct; 42(5):740-7. PubMed ID: 26433555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular oncology and the study of rare cancers.
    Margo CE
    Cancer Control; 2004; 11(5):283-4. PubMed ID: 15377986
    [No Abstract]   [Full Text] [Related]  

  • 9. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 10. Complementary and alternative medicine research and cooperative groups: can it happen?
    O'Mara A
    J Pediatr Oncol Nurs; 2006; 23(5):258-60. PubMed ID: 16902079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group.
    O'Leary M; Krailo M; Anderson JR; Reaman GH;
    Semin Oncol; 2008 Oct; 35(5):484-93. PubMed ID: 18929147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model network: Canadian program aims to generate models for rare disease.
    Foley KE
    Nat Med; 2015 Nov; 21(11):1242-3. PubMed ID: 26540381
    [No Abstract]   [Full Text] [Related]  

  • 13. Creating partnerships and improving health care: the role of genetic advocacy groups.
    Cody JD
    Genet Med; 2006 Dec; 8(12):797-9. PubMed ID: 17172944
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: traversing hurdles: the future of collaborative pediatric oncology research.
    Briery BG
    J Pediatr Psychol; 2005; 30(1):119-21. PubMed ID: 15610992
    [No Abstract]   [Full Text] [Related]  

  • 15. An ethnographic study of collaborative clinical trial protocol writing.
    Gennari JH; Weng C; McDonald DW; Benedetti J; Green S
    Stud Health Technol Inform; 2004; 107(Pt 2):1461-5. PubMed ID: 15361057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Representation of women as authors of collaborative cancer clinical trials.
    Sun GH; Moloci NM; Schmidt K; Maceachern MP; Jagsi R
    JAMA Intern Med; 2014 May; 174(5):806-8. PubMed ID: 24664468
    [No Abstract]   [Full Text] [Related]  

  • 17. Pond4Kids - an multi-site online Pediatric Oncology Research Database for collaborative protocol research.
    Quintana Y; Howard S; Norland M; Patel A; O'Brien R; Ribeiro R
    AMIA Annu Symp Proc; 2005; 2005():1090. PubMed ID: 16779377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethics bureaucracy: a significant hurdle for collaborative follow-up of drug effectiveness in rare childhood diseases.
    Hansson MG; Gattorno M; Forsberg JS; Feltelius N; Martini A; Ruperto N
    Arch Dis Child; 2012 Jun; 97(6):561-3. PubMed ID: 22362719
    [No Abstract]   [Full Text] [Related]  

  • 19. [Together for patients with hereditary neuromuscular conditions].
    Arntzen KA; Lund I; Rasmussen M; Rønningen KE; Torp TI; Ørstavik K
    Tidsskr Nor Laegeforen; 2016 Aug; 136(14-15):1198-9. PubMed ID: 27554555
    [No Abstract]   [Full Text] [Related]  

  • 20. The loneliness of fighting a rare cancer.
    Dockser Marcus A
    Health Aff (Millwood); 2010; 29(1):203-6. PubMed ID: 20048378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.